Richard F. Chambers

curasan AG engages in the developing, manufacturing and marketing of regenerative medicine. Its products cover the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company was founded by Hans Dieter Rössler in 1988 and is headquartered in Frankfurt, Germany.

ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany.

Anwerina AG is a pharmaceutical company based in Germany that specializes in the development of quality drugs and medical technology for the treatment of bone diseases. The Swiss company is experts in the field of osteoporosis and have a patient-centered strategy for the development of unique and cost-effective drugs. The private company offers ASCENDRA® / ASCENDRA® DUO / ASCENDRA® TRIO, which is an injection solution used for the therapy of osteoporosis in postmenopausal women with an increased risk of fractures. The company also focuses on the development of generic drugs for patients with bone metastases in the field of oncology.

Acxit Lifesciences GmbH provides financial and strategic advisory services. The private company is based in Frankfurt, Germany. Richard F. Chambers has been the CEO of the German company since 2004.